Research Awards — April 1-10, 2011

Federal Grants

Aguirre, Vincent, NIH, Melanocortin-4 Receptor-Dependent Regulation of Energy Balance After Gastric Bypass in Mice, $142,668; Baum, Michel, NIH, Neonatal Proximal Tubular Acidification (MPI), $273,827; Boothman, David, U.S. Dept. of Energy, Low Dose IR Activation of TGF-Beta 1-IGF-1-sCLU In Vivo: Mechanisms, Functions of Changing Microenvironment, $600,000; Bruick, Richard, NIH, Study of Iron-Responsive E3 Ligase Regulating Mammalian Iron Homeostasis, $314,000; Cannon, Stephen, NIH, Molecular Physiology of Myotonia and Periodic Paralysis, $349,697; Carr, Bruce, NIH, Clinical Evaluation of Levonorgestrel Butanoate for Female Contraception, $81,498; Carr, Bruce, NIH, NICHD Contraceptive Clinical Trials Network - Core Function Activities Task Order, $61,080; Cavanagh, Harrison, Jaeb Ctr. for Health/NIH, Cornea Donor Study, $75; Clegg, Deborah, Univ. of Cincinnati/NIH, Insulin and CNS Control of Body Weight and Food Intake, $20,515.

Cobb, Melanie, NIH, MAP Kinase in Islet Function, $385,415; Crandall, Craig, NIH, Control of Skin Blood Flow and Sweating in Grafted Skin, $293,138; Drazner, Mark, Duke Univ. Med. Ctr./NIH, STICH-Surgical Treatment of Ischemic Heart Failure, $150; Elmquist, Joel, Massachusetts General Hosp./NIH, Neuroendocrine Response to Gastric Bypass in Nonhuman Primates - ARRA Stimulus RC4, $117,285; Emslie, Graham, Univ. of Alabama at Birmingham/NIH, ATN Coordinating Center, $104,871; Falck, J. Russell, Vanderbilt Univ. Med. Ctr./NIH, Role of Icosanoids in Renal Function - Core C, $164,850; Feng, Pinghui, NIH, Post-translational Events Underlying the KSHV vGPCR Pathogenesis, $293,198; Freeman, Anne, Ctrs. for Disease Control and Prevention, Capacity-Building Assistance (CBA) to Improve Delivery and Effectiveness of HIV Prevention Services, $547,200; Garg, Abhimanyu, NIH, Genetic and Metabolic Basis of Familial Lipodystrophies, $545,866.

Gazdar, Adi, UT San Antonio/NIH, Multiplatform Approach to Biomarker Discovery in Lung Cancers in Never Smokers, $1,000,000; Gimpel, Nora, UNT Health Science Ctr./NIH, GoodNEWS (Genes, Nutrition, Exercise, Wellness and Spiritual Growth) Trial, $66,253; Goldberg, Mark Paul, Washington Univ. in St. Louis/NIH, Washington University Spotrias Center - Stroke Trials Registry/WEB Interface, $210,993; Goodman, Joel, NIH, Simple Cellular Model for Lipodystrophy, $279,774; Green, Carla, Northwestern Univ./NIH, Chemical and Genetic Manipulation of Circadian Systems-Project 4, $8,442; Grinnell, Frederick, NIH, Development of In Vitro Wound Healing Model, $421,990; Halm, Ethan, NIH, Long-Term Outcomes of Carotid Endarterectomy, $455,939; Halm, Ethan, NIH, Long-Term Outcomes of Carotid Endarterectomy - Diversity Supplement, $31,617; Hilgemann, Donald, NIH, Cardiac Function and PIP2, $381,100.

Hill, Joseph, NIH, Foxo: Negative Regulator of Cardiac Hypertrophy, $392,500; Husain, Mustafa, NIH, Prolonging Remission in Depressed Elderly (PRIDE), $187,309; Idris, Ahamed, Univ. of Washington/NIH, Resuscitation Outcomes Consortium Regional Clinical Center - ROC Protocols; #692487, $101,580; Jarrett, Robin, NIH, Prophylactic Cognitive Therapy for Depression, $286,205; Jiang, Li, NIH, Regulation of Adenylyl Cyclase VII and Its Function in Immune System (MPI), $286,769; Jiang, Qiu-Xing, NIH, 8K Camera for CryoEM at UT Southwestern, $599,723; Kliewer, Steven, NIH, Regulation of Metabolism by Hormone FGF15/19, $304,255; Koch, Joshua, Univ. of Michigan/NIH, Therapeutic Hypothermia after Pediatric Cardiac Arrest; THAPCA Trials, $13,107; Kohler, Jennifer, NIH, Discovery of Novel Cholera Toxin Receptors, $237,750; Kuro-o, Makoto, NIH, Effects of Klotho Protein on Aging and Metabolism, $281,033.

Leitch, Marilyn, Duke Univ. Med. Ctr./NIH, ACOSOG - Chair of Membership Committee, $12,600; Li, Shuxin, NIH, Overcoming Glial Scar Inhibitions on Axonal Growth, $178,313; Liu, Qinghua, NIH, Regulatory Mechanisms of RNA Interference, $251,797; Liu, Yi, NIH, Double-stranded RNA Mediated Signaling Pathway and Gene Silencing, $251,797; MacDonald, Raymond, Vanderbilt Univ. Med. Ctr./NIH, Genetic Control of Pancreatic Endocrine Cell Development, $198,125; Mason, Ralph, NIH, UT Southwestern Small Animal Imaging Resource (MPI), $406,238; McClintock, Shawn, NIH, Translational Research Evaluating Neurocognitive Memory Processes (TREC-MP), $129,972; McPhaul, Michael, NIH, Minority Predoctoral NLHBI Research Training at UT Southwestern, $118,364; Mohan, Chandra, NIH, Lupus Genes and B-Cell Signaling, $314,746; Norgard, Michael, UT Medical Branch at Galveston/NIH, Outer Membrane Proteins of Franciscella Tularensis as Acellular Vaccines, $337,463.

Olson, Eric (D. Millay, Fellow), NIH, Role of MicroRNA-206 in Skeletal Muscle Regeneration, $52,154; Olson, Eric (J. O'Rourke, Fellow), NIH, MicroRNA-29 iin Postnatal Skeletal Muscle Development and Disease, $50,474; Otwinowski, Zbyszek, Northwestern Univ./NIH, Center for Structural Genomics of Infectious Diseases, $63,890; Petroll, Matthew, NIH, Assessment of Corneal Fibroblast Biomechanical Behavior, $349,718; Punaro, Marilynn, Duke Univ. Med. Ctr./NIH, CARRANet: Accelerating Toward Evidence Based Culture in Pediatric Rheumatology - ARRA Stimulus Funding, $9,330; Raskin, Philip, Case Western Reserve Univ./NIH, Epidemiology of Diabetes Interventions and Complications - Clinical Coordinating Center (EDIC/CC), $260,554; Rodan, Aylin, NIH, Using Drosophila to Understand WNK and SPAK/OSR1 Regulation of SLC12 Cotransporters, $145,331.

Rogers, Zora, St. Jude Children’s Research Hosp./NIH, TCD with Transfusions Changing to Hydroxyurea (TWiTCH), $67,326; Rogers, Zora, ST. JUDE CHILDREN'S RES HOSP/NIH, Stroke with Transfusions Changing to Hydroxyurea (SWiTCH) - Extension Supplement, $22,362; Roland, Peter, VANDERBILT UNIV MED CTR/NIH, Clinical Validation and Testing of Percutaneous Cochlear Implantation, $4,200; Rothenfluh, Adrian, NIH, Control of Alcohol Responses by Actin-Regulating Genes, $338,794; Sanchez, Pablo, NIH, NICHD Cooperative Multicenter Neonatal Research Network, $317,000; Sanchez, Pablo, RTI INTERNATL/NIH, NICHD Cooperative Multicenter Neonatal Research Network - Capitation Payments, $12,973; Sanchez, Pablo, DUKE UNIV MED CTR/NIH, Fluconazole Prophylaxis for Prevention of Candidiasis in Infants < 750 Grams Birth Weight, $500; Seidel, Michelle, NIH, PDGF Receptor Signaling in Mammalian Development, $392,500.

Shaul, Philip, US DEPT OF DEFENSE, Breast Cancer Modulation by 27-Hydroxycholesterol, First Identified Endogenous SERM, $196,250; Shay, Jerry (Fellow A. Kaisani), US DEPT OF DEFENSE, Regulation of Angiogenesis by Homeobox Gene D10 (HoxD10) in Breast Cancer, $42,773; Takahashi, Joseph, UNIV OF CALIFORNIA, IRVINE/NIH, Control of Hair Follicle Cycling, $98,679; Tamminga, Carol, NIH, Antipsychotic Influence on Altered MTL Neuronal Activity in Schizophrenia, $353,250; Tamminga, Carol, BETH ISRAEL DEACONESS MED CTR/NIH, Bipolar-Schizophrenia Network for Immediate Phenotypes, $18,400; Terada, Lance, NIH, p47 Binding Partners in Endothelial Cell Function, $314,000; Thomas, Philip, NIH, Molecular Mechanisms of Ion Transport by the SMG, $335,496; Thomas, Philip, NIH, Development of Membrane Protein Structure, $297,259; Timmerman, Robert, AMER COLL OF RADIOLOGY/NIH, Radiation Therapy Oncology Group (RTOG), $600; Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node - Year 06 Supplements, $1,367,355; Wan, Yihong, NIH, Connection of Mineral and Energy Metabolism by Nuclear Receptor PPAR-Gamma, $344,738.

Weakley, David, EMORY UNIV/NIH, Infant Aphakia Treatment Study (IATS), $11,323; Weakley, David, JAEB CTR FOR HEALTH/NIH, Pediatric Eye Disease Investigator Group: Amblyopia Treatment Study, $467; Winick, Naomi, NATL CHILDHOOD CANCER FDN/NIH, COG Phase 1 Pilot Consortium PCR; #1021, $4,000; Winkler, Wade, NATL SCIENCE FDN, Investigation of Antitermination in Firmicutes, $209,166; Womack, Kyle, UNIV OF CALIFORNIA, SAN DIEGO/NIH, ADNI-GO: Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - ARRA Stimulus Funding, $8,250; Word, Ann, NIH, Elastic Fiber Homeostasis in Vaginal Wall, $281,033; Yin, Helen, NIH, Phosphoinositide Regulation of Golgi, $283,415; Yin, Helen, NIH, Phosphoinositide Regulation of Golgi - Diversity Suppl Lorente, $75,031; Yin, Helen, NIH, Phosphoinositide Regulation of Golgi - Diversity Suppl Gipson, $14,511; Zhang, Rong, NIH, Mild Cognitive Impairment: Cerebrovascular Dysfunction and Exercise Training (MPI) - Supplement Project, $423,879; Zinn, Andrew, NIH, SIM1 Function in Feeding Regulation, $304,255.

Non-Federal Grants

Argenbright, Keith, CANCER PREVENTION & RES INST OF TX, Fort Worth Program for Community Survivorship (ProComS), $406,658; Bibb, James, AMER CANCER SOC, Development of New Treatment Strategies for Men2 Cancer, $240,000; Cobb, Melanie (Fellow E. Dioum), JUVENILE DIABETES RES FDN, Signaling and Transcriptional Regulation in Enhanced Beta-Cell Function, $2,868; Cobb, Melanie (Fellow E. Dioum), JUVENILE DIABETES RES FDN, Signaling and Transcriptional Regulation in Enhanced Beta-Cell Function, $2,016; Feranchak, Andrew, CYSTIC FIBROSIS FDN, Development and Characterization of CF Biliary Epithelial Model, $43,200; Gao, Jinming, UNIV OF TX AT DALLAS/TX EMERGING TECH FUND, Dual MRI-Fluorescent Nanoprobes for Robotic Surgery of H and N Tumors, $100,000; Kohler, Jennifer, MIZUTANI FDN FOR GLYCOSCIENCE, Mechanisms for Discriminating Between NeuAc and NeuGc Incorporation, $48,857.

Lehrman, Mark, WELCH FDN, Novel Chemical Approaches for Exploring Dolichol-Linked Oligosaccharide Synthesis, $50,000; Mahendroo, Mala, BURROUGHS WELLCOME FUND, Dynamic Architecture of Cervical Collagen by SHG Endoscopy, $150,000; Mendelson, Carole, MARCH OF DIMES FDN, Cellular Mechanisms in Initiation of Labor, $136,916; Pagels, Patti, UNIV OF TX HEALTH SCI CTR AT SAN ANTONIO/UT SYSTEM, Health Literacy OSCE for Family Medicine Residents, $5,000; Powell, Craig (Fellow H. Speed), AUTISM SCIENCE FDN, Impairments in Synaptic Connectivity in Genetic Mouse Models of Autism Spectrum Disorders, $40,000; Rothenfluh, Adrian, NARSAD, Drosophila as Model Organism for Schizophrenia Endophenotypes, $30,000; Scherer, Philipp, ALBERT EINSTEIN COLL OF MEDICINE YU/NEW YORK STATE DEPT OF HEALTH, Identification of Adipocyte Cells in Adipose Tissue Turnover and Obesity, $60,000; Takahashi, Joseph (Fellow L. Pagani), SWISS NATL SCIENCE FDN, Molecular Circadian Rhythm Endophenotypes in Bipolar Disorder, $50,000.

Industry-Sponsored Awards, dollar amounts not available

Castro Borrero, Wanda, JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri®: STRATIFY-2; Gerber, David, Study of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Translocation or Inversion Involving Anaplastic Lymphoma Kinase (ALK) Gene Locus; Haley, Barbara, Study of T-DM1 Combined w/Pertuzumab or T-DM1 Comb w/Pertuzumab-Placebo vs Combination of Trastuzumab Plus Taxane as 1st Line Treatment in HER2-Positive Progressive or Recurrent Locally Advanced or Metastatic Breast Cancer; Kim, Mee Whi, Crystal Structure of Htt-Ex1 in Complex with Eukaryotic Chaperon TriC Apic Domain; Lotan, Yair, Study of Intraprostatic Administration of BOTOX® 200 U Purified Neurotoxin Complex to Treat Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia; Meyer, Dan, Clinical Trial to Evaluate HeartWare® Ventricular Assist System for Destination Therapy of Advanced Heart Failure.

Sharifi, Nima, Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy; Sharifi, Nima, PREVAIL: Study of Oral MDV3100 in Chemotherapy-Naïve Patients with Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy; Tibbals, Fred, Computerized Tonometry Maintenance 2011; Verma, Udit, Study of Two Dose Levels of TH-302 in Combination w/Gemcitabine Compared w/Gemcitabine Alone in Previously Untreated Patients with Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma; White, Perrin, Colesevelam Oral Suspension as Monotherapy or Add on to Metformin Therapy in Pediatric Subjects with Type 2 Diabetes Mellitus.

April 1-10, 2011 /

Share: